DDX41 and type 2 diabetes mellitus: GAD-Abs are most frequently used for assessment of autoantibodies as a marker of the autoimmune activity that distinguish LADA from T2D due to the fact that these antibodies are far more common in patients with adult onset autoimmune diabetes than other autoantibodies often found in children with T1D (32, 33).